Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2021-10-27 Proxy Solicitation & In…
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a '주주총회소집공고' (Notice of Convocation of General Meeting of Shareholders) which includes details about the meeting date, agenda items (such as the appointment of directors and amendments to the articles of incorporation), and voting procedures (including electronic voting). This document is a formal material sent to shareholders to provide information and request votes for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2021-10-27 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) filed by GtreeBNT. It details the date, time, location, and specific agenda items (such as the appointment of directors and auditors, and amendments to the articles of incorporation) for an upcoming Extraordinary General Meeting. This type of document is a standard proxy solicitation material provided to shareholders to inform them of meeting details and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2021-10-27 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation & Information Statement' (의결권대리행사권유참고서류) filed by G-treeBNT. It contains detailed information regarding an upcoming Extraordinary General Meeting, including the agenda (election of directors, appointment of auditors, amendment of articles of incorporation), proxy solicitation details, and candidate information. This document is designed to provide shareholders with the necessary information to cast their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2021-10-27 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It details specific changes to the bond maturity date, repayment schedule, and conversion options. In the context of Korean financial filings (DART system), this is a regulatory filing that updates the terms of a capital financing instrument. Since it is a formal amendment to a previous capital-related filing, it falls under the 'Capital/Financing Update' category.
2021-10-27 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '주요사항보고서(전환사채권발행결정)' (Major Report: Decision on Convertible Bond Issuance) and explicitly states it is a '정정신고(보고)' (Correction Report). It details changes to the terms of a convertible bond issuance, such as maturity dates, payment schedules, and conversion options. This falls under the category of capital and financing updates, specifically for convertible debt instruments.
2021-10-27 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a third-party capital increase (유상증자결정). It details the amendment of payment dates and listing dates for new shares, and provides comprehensive information on the capital increase, including the purpose, issuance price, and details of the third-party investors. This is a formal regulatory filing related to capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-10-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.